| DAA605 |
Bladder cancer |
Pathological |
bladder |
Human |
— |
SeriesMorbidity |
|
| DAA888 |
Glomeruli number decreases |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA887 |
Glomerular filtration rate declines |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA889 |
Glomeruli crowd together |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA890 |
IgM deposition in glomeruli |
Molecular |
glomerulus |
Human |
— |
— |
|
| DAA886 |
Renal arteriosclerosis |
Pathological |
renal vasculature |
Human |
— |
— |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA885 |
Renal blood flow declines |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA881 |
Dietary protein required to induce renal sclerotic lesions decreases |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA897 |
Response to antidiuretic hormone decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA898 |
Sodium conservation decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA899 |
Phosphate reabsorption decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA891 |
Nephrons appear to fail as units |
Physiological |
nephron |
Human |
— |
— |
|
| DAA287 |
creatine kinase, brain |
Molecular |
kidney |
Human |
CKB |
10.0% Decrease Gene Expression Level |
|
| DAA265 |
complement component 1, s subcomponent |
Molecular |
kidney |
Human |
C1S |
24.0% Increase Gene Expression Level |
|
| DAA289 |
brain protein 44-like |
Molecular |
kidney |
Human |
BRP44L |
9.0% Decrease Gene Expression Level |
|
| DAA288 |
complement component 1, r subcomponent |
Molecular |
kidney |
Human |
C1R |
21.0% Increase Gene Expression Level |
|
| DAA280 |
FXYD domain containing ion transport regulator 2 |
Molecular |
kidney |
Human |
FXYD2 |
5.0% Decrease Gene Expression Level |
|
| DAA275 |
complement component 1, q subcomponent, C chain |
Molecular |
kidney |
Human |
C1QC |
27.0% Increase Gene Expression Level |
|
| DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
Molecular |
kidney |
Human |
APBB1IP |
23.0% Increase Gene Expression Level |
|